NCT02226432Not yet recruiting
Combined Antagonistic Muscle Magnetic Stimulation and Selective Periferal Neurotomy to Improve Results on Spasticity
The Use of Antagonistic Muscle Magnetic Stimulation to Avoid Extensive Lesions and Improve Results of Selective Peripheral Neurotomy on Refractory and I POost Stroke Spasticity With Exclusive or Predominant Right Upper Limb Arm
Source: ClinicalTrials.gov · Last updated 19 Aug 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The objective of the present trial is to demonstrate Magnetic stimulation as an useful complementary treatment in order to improve patients' evolution without the need of extensive surgical lesion.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 15 (estimated)
- First submitted
- 16 Aug 2014
- Start date
- 1 Mar 2025
- Primary completion date
- 30 Nov 2026
- Lead sponsor
- Juan Carlos M. Andreani MD
- Diseases
- Stroke
- NCT number
- NCT02226432
What you commit to
- Study type: Interventional
- Planned participants: 15
- From 1 Mar 2025 to the primary completion date, 30 Nov 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Severe cardiovascular disease
- Severe pulmonary disease
- Neoplasia advanced disease
Other
- Joint anchylosis
- Irreversible retraction for muscle fibrosis
Who the study is looking for
- Severe and refractory right Hemiparesia or Hemiplegia, affecting hand function.
- Failure of kinesic treatment
- 2 points or more Improvement on Modified Ashworth Scale after anestethic blockade
Age in the registry: 25 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.